Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age

NCT04318548 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

945

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Meningococcal

Interventions

COMBINATION_PRODUCT: Meningococcal Group B Vaccine (GSK3536829A) (rMenB+OMV NZ)
BIOLOGICAL: Meningococcal MenACWY Conjugate Vaccine (GSK3536820A) (MenA lyo + MenCWY liquid)
COMBINATION_PRODUCT: Placebo

Sponsor

GlaxoSmithKline